Trial help
Hello all,
Can't decide between 2 trials. I'm eligible for both. The first is NCT01532960, pilot study of a breast cancer vaccine plus poly-ICLC for breast cancer the second is NCT01632332, Vaccine therapy in treating patients with previously treated stage ll-lll HER2 positive breast cancer.
I was hoping someone could explain the difference and if one would be better than the other. They're both phase 1 and seem to both be Peptide vaccines.
Thanks,
Denise
|